Prevalence and Factors of Sarcopenia and in Patients With Primary Sjogren's Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-08-12

Study Completion Date

2022-05-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sarcopenia is a progressive condition characterized by decline in muscle strength and muscle mass. Although the mechanism of sarcopenia has not been fully elucidated, it may be caused by protein-poor diet, vitamin D deficiency, hormonal changes, increase in inflammatory cytokine level and oxidative stress. For this reason, it is thought that determining the prevalence of sarcopenia in rheumatological diseases with chronic inflammation and protecting patients from possible comorbidities with appropriate interventions may be an important factor in maintaining and improving the functional levels and quality of life of patients.

The aim of our study was to investigate the prevalence and its associated factors of sarcopenia in individuals with primary Sjögren's Syndrome.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Investigation of Respiratory Muscle Sarcopenia in Patients with Systemic Sclerosis

NCT06598982

Systemic Sclerosis (SSc) Scleroderma

RECRUITING

Interstitial Lung Diseases in Primary Sjogren's Syndrome

NCT04978883

Sjogren's Syndrome

COMPLETED

Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome

NCT05380804

Small Fiber Neuropathy Primary Sjögren Syndrome

COMPLETED

Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy

NCT03509064

Primary Sjögren Syndrome Small Fiber Neuropathy Quality of Life +1 more

RECRUITING

Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers

NCT01971957

Sjogren-Larsson Syndrome (SLS)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia Sjogren's Syndrome Rheumatologic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Primary Sjogren's Syndrome

Participants with Primary Sjogren's Syndrome

Sarcopenia Assessment

Intervention Type OTHER

Sarcopenia Assessment

Control group

Healthy controls

Sarcopenia Assessment

Intervention Type OTHER

Sarcopenia Assessment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sarcopenia Assessment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with primary Sjogren's syndrome by an experienced rheumatologist according to European League Against Rheumatism (EULAR) ve American College of Rheumatology (ACR) criteria
* Being 40 years or older.

Exclusion Criteria

* Pregnancy,
* Malignancy,
* Presence of other rheumatological diseases,
* Presence of diabetes mellitus
* Presence of neurological problems
* Presence of osteoarthritis

Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No